Short-Term Outcomes of Dual Versus Single Antiplatelet Therapy Following Popliteal and Infrapopliteal Endovascular Therapy: Data From Dutch Chronic Lower Limb-Threatening Ischemia Registry (THRILLER)

This manuscript reports on the efficacy and safety outcomes of 3 months of DAPT versus SAPT, which are commonly chosen therapies following popliteal and infrapopliteal endovascular therapy. No significant difference was found between the two groups regarding major adverse cardiovascular events, all-cause death, major amputation, or major bleeding. Therefore, 3 months of DAPT does not seem superior to SAPT. These results suggest that SAPT appears to be a sufficient alternative when considering 3 months of DAPT. Further research should verify these outcomes and focus on the efficacy and safety of prolonged DAPT suppletion after endovascular therapy.

Authors

Institutions

Publication Details

Journal
Journal of Endovascular Therapy
Published
2025-01-22
DOI
https://doi.org/10.1177/15266028241312356
Primary Topic
Peripheral Artery Disease Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Short-Term Outcomes of Dual Versus Single Antiplatelet Therapy Following Popliteal and Infrapopliteal Endovascular Therapy: Data From Dutch Chronic Lower Limb-Threatening Ischemia Registry (THRILLER)

Constantijn E.V.B. Hazenberg, Çağdaş Ünlü, Daniël A. F. van den Heuvel, Gert J. de Borst et al.
Journal of Endovascular Therapy
Peripheral Artery Disease Management
article

Short-Term Outcomes of Dual Versus Single Antiplatelet Therapy Following Popliteal and Infrapopliteal Endovascular Therapy: Data From Dutch Chronic Lower Limb-Threatening Ischemia Registry (THRILLER)

Constantijn E.V.B. Hazenberg, Çağdaş Ünlü, Daniël A. F. van den Heuvel, Gert J. de Borst, Jan-Willem Hinnen, M.E. Pierie, Bram Fioole, Olaf J. Bakker, Olaf Schouten, G.P. Akkersdijk, Michiel A. Schreve, M.K. Dinkelman, Jan M.M. Heyligers, Michael J. Nugteren, Emilien C. J. Wegerif, Bart A.N. Verhoeven, Isa F. van Galen
article en

Abstract

This manuscript reports on the efficacy and safety outcomes of 3 months of DAPT versus SAPT, which are commonly chosen therapies following popliteal and infrapopliteal endovascular therapy. No significant difference was found between the two groups regarding major adverse cardiovascular events, all-cause death, major amputation, or major bleeding. Therefore, 3 months of DAPT does not seem superior to SAPT. These results suggest that SAPT appears to be a sufficient alternative when considering 3 months of DAPT. Further research should verify these outcomes and focus on the efficacy and safety of prolonged DAPT suppletion after endovascular therapy.

Journal of Endovascular Therapy
University Medical Center Utrecht (NL), Northwest Hospital (US), St. Antonius Ziekenhuis (NL), Maasstad Ziekenhuis (NL), Isala (NL), Elisabeth-TweeSteden Ziekenhuis (NL), Jeroen Bosch Ziekenhuis (NL)
Good health and well-being
Openalex Percentile: Top 98%
Peripheral Artery Disease Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.